Abstract
Purpose
There is a lack of knowledge about neurobehavioral performance among patients with manganism and how their performance differs from that of idiopathic Parkinson disease patients (PD). This study was initiated with the aim to describe and compare neurobehavioral performance among patients diagnosed with manganism, PD and a group of referents.
Materials and methods
Neurobehavioral performance was assessed in 34 patients diagnosed with manganism, 13 with PD, and 43 healthy workers (turners/fitters) who served as the reference group. Seventeen of the manganism patients had also been tested approximately 65 months previously.
Results
Manganism patients scored substantially more poorly than referents on tests for motor speed, manual dexterity and balance. They also performed more poorly than the PD patients on the postural sway test. In contrast, the PD patients had higher postural tremor intensity with narrower frequency dispersion than manganism patients. The pattern of neurobehavioral performance was more asymmetrical in PD compared to manganism patients, in particular when testing for tremor intestity, grooved pegboard and static steadiness, indicating lateralized impairment in the PD patients. The amount of bradykinesia was comparable between the patient groups. Neurobehavioral performance deteriorated slightly among 17 manganism patients followed for 65 months compared with the age-related decline among referents.
Conclusions
Patients with manganism had severe bradykinesia and balance disturbances, but only slight postural tremor. In contrast, PD patients had significant postural tremor and bradykinesia, but only slight balance disturbances. Their neurobehavioral performance indicated lateralized impairment, more unilateral. Neurobehavioral performance deteriorated slightly in manganism patients during a 65-month follow-up.
Similar content being viewed by others
References
Bast-Pettersen R, Ellingsen DG (2005) The Klove-Matthews static steadiness test compared with the DPD TREMOR—comparison of a fine motor control task with measures of tremor in smokers and manganese-exposed workers. Neurotoxicology 26:331–342
Calne DB, Chu N-S, Huang C-C, Lu C-S, Olanow W (1994) Manganism and idiopathic parkinsonism: Similarities and differences. Neurology 44:1583–1586
Chin-Chang H, Nai-Shin C, Chin-Song L, Wang JD, Tsai JL, Tzeng JL et al (1989) Chronic manganese intoxication. Arch Neurol 46:1104–1106
Collomb-Clerc A, Welter M-L (2015) Effects of deep brain stimulation on balance and gait in patients with Parkinson’s disease: a systematic neurophysiological review. Clin Neurophysiol 45:371–388
Couper J (1837) On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol 1:41–42
Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM et al (2011) Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology 76:1296–1301
Crossgrove J, Zheng W (2004) Manganese toxicity upon overexposure. NMR Biomed 17:544–553
Després C, Lamoureux D, Beuter A (2000) Standardization of neuromotor test battery: the CATSYS system. Neurotoxicology 21:725–736
Dickson DW (2012) Parkinson’s disease and parkinsonism: Neuropathology. Cold Spring Harb Perspect Med 2:a009258
Drogichina EA (1968) Occupational diseases of the nervous system. Medicina, Leningrad, p 259 (In Russian)
Ellingsen DG, Konstantinov R, Bast-Pettersen R, Merkurjeva L, Chashchin M, Thomassen Y et al (2008) A neurobehavioral study of current and former welders exposed to manganese. Neurotoxicology 29(1):48–59
Ellingsen DG, Zibarev E, Kusraeva Z, Berlinger B, Chashchin M, Bast-Pettersen R et al (2013) The bioavailability of manganese in welders in relation to its solubility in welding fumes. Environ Sci 15:357–365
Ellingsen DG, Kusraeva Z, Bast-Pettersen R, Zibarev E, Chashchin M, Thomassen Y et al (2014) The interaction between manganese exposure and alcohol on neurobehavioral outcomes in welders. Neurotoxicol Teratol 41:8–15
Ellingsen DG, Chashchin M, Bast-Pettersen R, Zibarev E, Thomassen Y, Chashchin V (2015) A follow-up study of neurobehavioral functions in welders exposed to manganese. Neurotoxicology 47:8–16
Emara AM, El-Ghawabi SH, Madkour OI, El-Samra GH (1971) Chronic manganese poisoning in the dry battery industry. Br J Ind Med 28:78–82
Farkas Z, Csillik A, Szirmai I, Kamondi A (2006) Assymmetry of tremor intensity and frequency in Parkinson’s disease and essential tremor. Parkinsonism Relat Disorders 12:49–55
Felicio AC, Shih MC, Godeiro-Junior C, Andrade LA, Bressan RA, Ferraz HB (2009) Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty. Neurologist 15:6–16
Gelb DJ, Oliver E, Gilmanv S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39
Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C et al (2004) Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. The movement disorder society task force on rating scales for Parkinson’s disease. Mov Dis 19(9):1020–1028
Grigoriev P, Meslé F, Shkolnikov VM, Andreev E, Fihel A, Pechholdova M et al (2014) The recent mortality decline in Russia: Beginning of the cardiovascular revolution. Popul Dev Rev 40:107–129
Guilarte T (2010) Manganese and Parkinson’s disease: a critical review and new findings. Environ Health Perspect 118(8):1071–1080
Guilarte TR, Gonzales KK (2015) Manganese-induced parkinsonism is not idiopathic Parkinson’s disease: genetic and environmental evidence. Toxicol Sci 146:204–212, 2015
Han JH, Chung YH, Park JD, Kim CY, Yang SO, Khang HS et al (2008) Recovery from welding fume exposure induced MRI T1 signal intensities after cessation of welding fume exposure in brains of cynomolgus monkeys. Inhal Toxicol 20:1075–1083
Heaton RK, Miller W, Taylor MJ, Grant I (2004) Revised comprehensive norms for an expanded Halstead-Reitan battery. In: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources Inc, Lutz, FL, USA
Hoehn M, Yahr M (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442
Huang C-C, Lu C-S, Chu N-S, Hochberg F, Lilienfeld D, Olanow W et al (1998) Progression after chronic manganese exposure. Neurology 43:1479–1483
Kim Y, Kim J-W, Ito K, Lim H-S, Cheong H-K, Kim JY et al (1999) Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Neurotoxicology 20:249–252
Levin OS, Fedorova NV (2012) Parkinson’s disease. MEDpress-inform, Moscow
Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological assessment, 5th edn. Oxford University Press, Oxford
Lucchini RG, Aschner M, Kim Y, Šarić M (2015) Manganese. In. Nordberg G, Fowler BA, Nordberg M (eds) Handbook on the toxicology of metals, 4th edn. Academic Press, London, UK, pp 975–1011
Lundberg I, Högberg M, Michélsen H, Nise G, Hogstedt C (1997) Evaluation of the Q16 questionnaire on neurotoxic symptoms and a review of its use. Occup Environ Med 54:343–350
Matthews CG, Kløve H (1964) Instruction manual for the adult neuropsychological test battery. University of Wisconsin Medical School, Madison
Melnikova MM (1995) Manganese poisoning. Med Truda I Promyshlennaia Ekol 6:21–24
Meng A, Nexo MA, Borg V. The impact of retirement on age related cognitive decline—a systematic review. BMC Geriatr 2017;17(160). https://doi.org/10.1186/s12877-017-0556-7
Meyer-Baron M, Schäper M, Knapp G, Lucchini R, Albini E, Bast-Pettersen R et al (2013) The neurobehavioral impact of manganese—results and challenges obtained by a meta-analysis of individual participant data. Neurotoxicology 36:1–9
Newland MC, Cox C, Hamada R, Oberdörster G, Weiss B (1987) The clearance of manganese chloride in the primate. Fundam Appl Toxicol 9:314–328
Olanow CW (2004) Manganese-induced parkinsonism and Parkinson’s disease. Ann NY Acad 1012:209–223
Perl DP, Olanow CW (2007) The neuropathology of manganese-induced parkinsonism. J Neuropathol Exp Neurol 66:675–682
Redfern MS, Yardley L, Bronstein AM (2001) Visual influence on balance. J Anxiety Disord 15:81–94
Reitan RM, Wolfson D (1985) The halstead-reitan neuropsychological test battery. Theory and clinical implication. Neuropsychology Press, Tucson, Arizona, USA
Rodier J (1955) Manganese poisoning in moroccan miners. Br J Ind Med 12:21–35
Sibon I, Fenelon G, Quinn NP, Tison F (2004) Vascular parkinsonism. J Neurol 251:513–524
Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests: administration, norms and commentary, 3rd edn. Oxford University Press, New York
Takagi Y, Okada A, Sando K, Wasa M, Yoshida H, Hirabuki N (2001) On-off study of manganese administration to adult patients undergoing home parenteral nutrition: New indices of in vivo manganese level. J Parenter Enteral Nutr 25(2):87–92
Tanaka S, Lieben J (1969) Manganese poisoning and exposure in Pennsylvania. Arch Environ Health 19:674–684
Thanvi B, Lo N, Robinson T (2005) Vascular parkinsonism—an important cause of parkinsonism in older people. Age Ageing 34:114–119
Triumfov AV (1998) Parkinsonism. Topical diagnostics of nervous system diseases. Moscow, 304 (in Russian)
Wang JD, Huang CC, Hwang YH, Chiang JR, Lin JM, Chen JS (1989) Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med 46:856–859
Wirdefeldt K, Adami H-O, Cole P, Trichopoulos D, Mandel J (2011) Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol 26:S1–S58
Wolters ECH, Huang C-C, Clark C, Peppard RF, Okada J, Chu N-S et al (1989) Positron emission tomography in manganese intoxication. Ann Neurol 26:647–651
Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H et al (1986) Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol (Berl) 70:273–278
Acknowledgements
The study was supported by Grant Number W81XWH-05-1-0239 from the National Institutes of Health, the United States Department of Defense, and the United States Army Medical Research and Materiel Command through Vanderbilt University. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health, the United States Department of Defense, the United States Army Medical Research and Materiel Command or Vanderbilt University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by the Norwegian Regional Ethical Committee for Medical Research (REK2), the Ethics Committee of the NWPHRC (St. Petersburg, Russia), and the Office of Research Protection, US Army Medical Research and Materiel Command (Fort Detrick, MD, USA). Participation was voluntary. Informed written consent was obtained from each participant.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ellingsen, D.G., Shvartsman, G., Bast-Pettersen, R. et al. Neurobehavioral performance of patients diagnosed with manganism and idiopathic Parkinson disease. Int Arch Occup Environ Health 92, 383–394 (2019). https://doi.org/10.1007/s00420-019-01415-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00420-019-01415-6